You are here

  • Home
  • Archive
  • Volume 77, Issue Suppl 2
  • FRI0108 Golimumab improves work productivity and activity and quality of life in patients with rheumatoid arthritis (RA), psoriasis arthritis (PSA) and axial spondyloarthritis (AXSPA): interim results from a non-interventional study in austria (go active)

Article metrics

Article menu

Download PDFPDF

FRIDAY, 15 JUNE 2018
Rheumatoid arthritis – biological DMARDs
FRI0108 Golimumab improves work productivity and activity and quality of life in patients with rheumatoid arthritis (RA), psoriasis arthritis (PSA) and axial spondyloarthritis (AXSPA): interim results from a non-interventional study in austria (go active)
Free

 

Online download statistics by month:

Online download statistics by month: June 2018 to March 2024

AbstractFullPdf
Jun 20183209
Jul 20183805
Aug 20183006
Sep 20181006
Oct 201832016
Nov 20183208
Dec 20182003
Jan 20193201
Feb 20191501
Mar 201948010
Apr 20192205
May 201926010
Jun 20192202
Jul 20192609
Aug 20191207
Sep 20191200
Oct 20191805
Nov 20192003
Dec 20191600
Jan 20201202
Feb 2020603
Mar 2020401
Apr 2020201
May 2020602
Jun 20201403
Jul 20201202
Aug 20202002
Sep 20203002
Oct 20202203
Nov 20201200
Dec 20201404
Jan 2021400
Feb 20211205
Mar 2021600
Apr 2021403
May 20212608
Jun 2021002
Jul 2021105
Aug 2021003
Sep 2021106
Oct 202110020
Nov 202114017
Dec 20211005
Jan 2022602
Feb 2022800
Mar 20221004
Apr 20221002
May 2022608
Jun 20222004
Jul 20221203
Aug 20222003
Sep 20221006
Oct 2022804
Nov 20221204
Dec 20221000
Jan 2023504
Feb 20231402
Mar 20231600
Apr 2023400
May 2023002
Jun 2023402
Jul 2023804
Aug 2023203
Sep 2023202
Oct 2023601
Nov 20231202
Dec 20231402
Jan 20241801
Feb 2024602
Mar 202420128
Total9500400